MedTrace Logo

rTMS Effect on Cognitive and Psychiatric Dysfunction in Patients With Fibromyalgia

NCT06356805 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2024-04-10

No results posted yet for this study

Summary

the aim of this work was to evaluate the effect of low frequency rTMS over the right dorsolateral prefrontal area (DLPFC) on Fibromyalgia patients. Fibromyalgia Impact Questionnaire (FIQ), Hamilton depression and Anxiety scale and different cognitive rating scales were evaluated pre-1 month post sessions and pre -post 3 months later. all eligible patients with fibromyalgia (FM) were randomized to have 20 sessions of active or sham rTMS over right DLPFC. The improvement changes in groups were compared in each rating scale.

Conditions

  • Treatment Resistant Disorders

Interventions

DEVICE

repetitive transcranial magnetic stimulation

Parallel study: Participants are assigned to one of two groups in parallel for 3 months follow up

Sponsors & Collaborators

  • Tanta University

    collaborator OTHER

  • Assiut University

    lead OTHER

Principal Investigators

  • Eman Khedr, professor · Assiut University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-10
Primary Completion
2024-01-30
Completion
2024-02-20

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06356805 on ClinicalTrials.gov